Session information

Session

[Session 11] Drug Interaction

Sun. Jun 14, 2015 4:20 PM - 6:20 PM Hall A (International Conference Room 1F)

Chair:Yoshiro Saito (Medicinal Safety Science, National Institute of Health Sciences), Chair:Kiyomi Ito (Research Institute of Pharmaceutical Sciences, Musashino University)

+Add all to schedule

[Session 11-1] Use of modeling and simulation for the prediction of drug interactions

^○Kiyomi Ito (Research Institute of Pharmaceutical Sciences, Musashino University)

[Session 11-2] Japanese final draft guideline on drug interaction studies for drug development and labeling recommendations

^○Yoshiro Saito (Medicinal Safety Science, National Institute of Health Sciences)

[Session 11-3] A Scientific Perspective on Drug Interaction Evaluation in Drug Development

^○Lei Zhang (USA)

[Session 11-4] The practical aspects of complying with regulatory guidelines on drug interactions: Some notable strengths and weaknesses of in vitro testing

^○Andrew Parkinson (CYP450, XPD Consulting)

▲